PRESS RELEASE published on 10/10/2023 at 21:10, 2 years 7 months ago Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company's Assets and Adjustment of Guidance for 2023
PRESS RELEASE published on 10/10/2023 at 20:56, 2 years 7 months ago EQS-Adhoc: Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023
PRESS RELEASE published on 09/11/2023 at 15:54, 2 years 8 months ago EQS-Adhoc: Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company
PRESS RELEASE published on 09/05/2023 at 17:20, 2 years 8 months ago Epigenomics AG: Pareto and Warburg publish analyst research reports
PRESS RELEASE published on 08/10/2023 at 08:00, 2 years 9 months ago Epigenomics AG publishes financial results for the first six months 2023
PRESS RELEASE published on 08/02/2023 at 10:36, 2 years 9 months ago EQS-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 5 : 1
PRESS RELEASE published on 07/24/2023 at 18:40, 2 years 9 months ago Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets
PRESS RELEASE published on 07/24/2023 at 18:29, 2 years 9 months ago EQS-Adhoc: Epigenomics AG: Agreement on the Acquisition of Almost All Assets
PRESS RELEASE published on 06/12/2023 at 10:21, 2 years 11 months ago EQS-Adhoc: Epigenomics AG: Negotiations on the Acquisitions of Almost All Assets
PRESS RELEASE published on 05/31/2023 at 08:00, 2 years 11 months ago Epigenomics AG Reports Financial Results for the First Quarter of 2023
Published on 05/16/2026 at 01:15, 1 day 21 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 23 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 2 days ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/16/2026 at 16:08, 1 day 7 hours ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 2 days 3 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 2 days 5 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 2 days 8 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 2 days 8 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 2 days 13 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days 14 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 4 days 5 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
